[1] |
MORGAN E, ARNOLD M, CAMARGO M C, et al. The current and future incidence and mortality of gastric cancer in 185 countries,2020-40:a population-based modelling study[J]. EClinicalMedicine, 2022,47:101404.
|
[2] |
LI H, ZHANG H, ZHANG H, et al. Survival of gastric cancer in China from 2000 to 2022:a nationwide systematic review of hospital-based studies[J]. J Glob Health, 2022,12:11014.
|
[3] |
CHON S H, BERLTH F, PLUM P S, et al. Gastric cancer treatment in the world:Germany[J]. Transl Gastroenterol Hepatol, 2017,2:53.
|
[4] |
LAI J P, SANDHU D S, SHIRE A M, et al. The tumor suppressor function of human sulfatase 1(SULF1)in carcinogenesis[J]. J Gastrointest Cancer, 2008, 39(1):149-158.
|
[5] |
CHEN J, CHEN T, ZHU Y, et al. CircPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma[J]. J Exp Clin Cancer Res, 2019, 38(1):398.
DOI
PMID
|
[6] |
HUR K, HAN T S, JUNG E J, et al. Up-regulated expression of sulfatases(SULF1 and SULF2)as prognostic and metastasis predictive markers in human gastric cancer[J]. J Pathol, 2012, 228(1):88-98.
|
[7] |
NARITA K, STAUB J, CHIEN J, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo[J]. Cancer Res, 2006, 66(12):6025-6032.
|
[8] |
宫伟, 李涛. 硫酸酯酶1(SULF1)与结肠癌预后相关性及其机制的生物信息学分析[J]. 细胞与分子免疫学杂志, 2019, 35(11):1008-1013.
|
[9] |
LI J, WANG X, LI Z, et al. SULF1 activates the VEGFR2/PI3K/AKT pathway to promote the development of cervical cancer[J]. Curr Cancer Drug Targets, 2024, 24(8):820-834.
|
[10] |
LAI J P, YU C, MOSER C D, et al. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma[J]. Gastroenterology, 2006, 130(7):2130-2144.
|
[11] |
CHEN F, ZHANG Z, YU Y, et al. HSulf1 and palbociclib exert synergistic antitumor effects on RB-positive triplenegative breast cancer[J]. Int J Oncol, 2020, 57(1):223-236.
|
[12] |
LYU Y, CHENG Y, WANG B, et al. Sulfatase 1 expression in pancreatic cancer and its correlation with clinicopathological features and postoperative prognosis[J]. Cancer Biomark, 2018, 22(4):701-707.
DOI
PMID
|
[13] |
YANG Y, AHN J, EDWARDS N J, et al. Extracellular heparan 6-O-endosulfatases SULF1 and SULF2 in head and neck squamous cell carcinoma and other malignancies[J]. Cancers(Basel), 2022, 14(22):5553.
|
[14] |
HAN C H, HUANG Y J, LU K H, et al. Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer[J]. J Exp Clin Cancer Res, 2011, 30(1):5.
|
[15] |
CHEN L M, NIU Y D, XIAO M, et al. LncRNA NEAT1 regulated cell proliferation,invasion,migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer[J]. Eur Rev Med Pharmacol Sci, 2020, 24(9):4810-4821.
|
[16] |
LEE H Y, YEH B W, CHAN T C, et al. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract[J]. Oncotarget, 2017, 8(29):47216-47229.
|